As Nrf2 activation in astrocytes is known to undergo changes in the human demyelinating disease multiple sclerosis (MS)19,38,39, we investigated whether this was associated with altered cholesterol biosynthesis pathway activation. Here, NFE2L2 is linked to myeloid sarcoma.